+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Ultraviolet B radiation-induced production of interleukin 1alpha and interleukin 6 in a human squamous carcinoma cell line is wavelength-dependent and can be inhibited by pharmacological agents



Ultraviolet B radiation-induced production of interleukin 1alpha and interleukin 6 in a human squamous carcinoma cell line is wavelength-dependent and can be inhibited by pharmacological agents



British Journal of Dermatology 139(3): 415-421



Ultraviolet (UV) B irradiation induces keratinocytes to produce among others the proinflammatory cytokines interleukin (IL) 1 and IL-6. The wavelength dependence of this UVB effect has not yet been assessed. We evaluated the potential of different UVB wavelength regions to release cytokines from the squamous carcinoma cell line SCL II and also assessed the effect of various putative inhibitors. Confluent monolayers of the cells were irradiated with 0.5-2.0 mJ/cm2 UVB at 280, 290, 300, 310 or 320 (each +/- 5) nm. In additional experiments dexamethasone (10-9-10-5 mol/L), ascorbic acid, d-alpha-tocopherol or indomethacin (each 10-7-10-4 mol/L) were added to the culture medium 24 h before, immediately after or combined before and after irradiation with 1 mJ/cm2 UVB at 280 +/- 5 nm. Supernatants of the cell cultures were recovered at 24 h after irradiation, and IL-1alpha or IL-6 were determined by an enzyme-linked immunosorbent assay (ELISA). IL-1alpha and IL-6 production were induced by UVB at 280, 290 and 300 nm, the production depended on the UV dose and decreased with increasing wavelengths. Irradiation at 310 or 320 nm did not induce cytokine production up to the maximum dose used. The production of IL-1 alpha/IL-6 was inhibited up to 80/89% (10-7-10-6 mol/L before and after irradiation) by dexamethasone in a concentration-dependent manner and with all conditions of incubation. Release of cytokines was also suppressed by indomethacin, d-alpha-tocopherol or ascorbic acid, but concentration dependence was not always evident. These results show that particularly shorter UVB radiation, which is expected to increase due to stratospheric ozone depletion, induces prominent production of proinflammatory cytokines, indicating major biological effects. Different pharmacological compounds can interfere with this effect and seem worth further evaluation with regard to their clinical effects.

(PDF emailed within 1 workday: $29.90)

Accession: 009693977

Download citation: RISBibTeXText

PMID: 9767285


Related references

Effects of interleukin-1alpha, interleukin-1 receptor antagonist, and neutralizing antibody on proinflammatory cytokine expression by human squamous cell carcinoma lines. Cancer Research 58(16): 3668-3676, 1998

Opposing effects of ultraviolet B irradiation on interleukin-1 receptor antagonist and interleukin-1 alpha messenger RNA expression in a human epidermoid carcinoma cell line. Photodermatology, Photoimmunology & Photomedicine 11(3): 91-94, 1995

Interleukin-8 and monocyte chemotactic protein-1 production by a human glioblastoma cell line, T98G in coculture with monocytes: involvement of monocyte-derived interleukin-1alpha. European Cytokine Network 9(1): 47-55, 1998

Production of interleukin-1alpha by human endometrial stromal cells is triggered during menses and dysfunctional bleeding and is induced in culture by epithelial interleukin-1alpha released upon ovarian steroids withdrawal. Journal of Clinical Endocrinology and Metabolism 93(10): 4126-4134, 2008

Production of interleukin-1 and interleukin-6 by human keratinocytes and squamous cell carcinoma cell lines. Journal of Investigative Dermatology 96(5): 771-776, 1991

Nuclear factor kB (NF-kB), nuclear factor interleukin-6 (NFIL-6 or C/EBPb) and nuclear factor interleukin-6b (NFIL6-b or C/EBPd) are not sufficient to activate the endogenous interleukin-6 gene in the human breast carcinoma cell line MCF-7. Comparative analysis with MDA-MB-231 cells, an interleukin-6-expressing human breast carcinoma cell line. European Journal of Biochemistry 239: 4-31, 1996

Nuclear factor kappa-B , nuclear factor interleukin-6 and nuclear factor interleukin-6-beta are not sufficient to activate the endogenous interleukin-6 gene in the human breast carcinoma cell line MCF-7 Comparative analysis with MDA-MB-231 cells, an interleukin-6-expressing human breast carcinoma cell line. European Journal of Biochemistry 239(3): 624-631, 1996

Wavelength-specific synergy between ultraviolet radiation and interleukin-1alpha in the regulation of matrix-related genes: Mechanistic role for tumor necrosis factor-alpha. Journal of Investigative Dermatology 113(2): 196-201, 1999

Capacity of alloreactive human t clones to produce factors inducing proliferation of the interleukin 3 dependent da 1 murine cell line i. evidence that this production is under interleukin 2 control. Annales de l'Institut Pasteur Immunology 137(1): 25-38, 1986

Effect of pharmacological agents on the production of interleukin-10 by the murine D10.G4.1 T-h 2 cell line in vitro. International Journal of Immunopharmacology 17(7): 619-625, 1995

Intracellular interleukin-1alpha mediates interleukin-8 production induced by Chlamydia trachomatis infection via a mechanism independent of type I interleukin-1 receptor. Infection and Immunity 76(3): 942-951, 2007

Spontaneous production of a suppressor factor by the human macrophage-like cell line U937. I. Suppression of interleukin 1, interleukin 2, and mitogen-induced blastogenesis in mouse thymocytes. Journal of Immunology 136(1): 181-185, 1986

Immunosuppressive effect on T cell activation by interleukin-16- and interleukin-10-cDNA-double-transfected human squamous cell line. Burns 35(3): 383-389, 2008

Nuclear factor kappa B (NF-kappa B), nuclear factor interleukin-6 (NFIL-6 or C/EBP beta) and nuclear factor interleukin-6 beta (NFIL6-beta or C/EBP delta) are not sufficient to activate the endogenous interleukin-6 gene in the human breast carcinoma cell line MCF-7. Comparative analysis with MDA-MB-231 cells, an interleukin-6-expressing human breast carcinoma cell line. European Journal of Biochemistry 239(3): 624-631, 1996